LUCAS WONG to Prognosis
This is a "connection" page, showing publications LUCAS WONG has written about Prognosis.
Connection Strength
0.010
-
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336). Invest New Drugs. 2009 Oct; 27(5):469-75.
Score: 0.010
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.